GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Sale Of Business

Beximco Pharmaceuticals (DHA:BXPHARMA) Sale Of Business : BDT0 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Sale Of Business?

Beximco Pharmaceuticals's sale of business for the three months ended in Dec. 2023 was BDT0 Mil. It means Beximco Pharmaceuticals gained BDT0 Mil from selling business. Beximco Pharmaceuticals's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was BDT0 Mil.

Compared with last quarter (BDT0 Mil in Jun. 2023 ), Beximco Pharmaceuticals gained the same money from selling business in Dec. 2023 (BDT0 Mil).

Beximco Pharmaceuticals Sale Of Business Historical Data

The historical data trend for Beximco Pharmaceuticals's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Sale Of Business Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beximco Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Beximco Pharmaceuticals Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Sale Of Business Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Sale Of Business
Comparable Companies
DHA:BEACONPHAR DHA:ACMELAB DHA:RENATA DHA:ORIONINFU DHA:ASIATICLAB DHA:CENTRALPHL DHA:SQURPHARMA ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB
Traded in Other Exchanges
BXP:UK R2WA:Germany
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Website
https://www.beximcopharma.com
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines